DK0463061T3 - Controlled-release tilførselsindretning til afgivelse af makromolekylære proteiner - Google Patents

Controlled-release tilførselsindretning til afgivelse af makromolekylære proteiner

Info

Publication number
DK0463061T3
DK0463061T3 DK90905065.0T DK90905065T DK0463061T3 DK 0463061 T3 DK0463061 T3 DK 0463061T3 DK 90905065 T DK90905065 T DK 90905065T DK 0463061 T3 DK0463061 T3 DK 0463061T3
Authority
DK
Denmark
Prior art keywords
beadlets
delivery device
animal
controlled
macromolecular
Prior art date
Application number
DK90905065.0T
Other languages
Danish (da)
English (en)
Inventor
Kallidaikuruc Sivaramakrishnan
Lindy F Miller
Original Assignee
Pitman Moore Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pitman Moore Inc filed Critical Pitman Moore Inc
Application granted granted Critical
Publication of DK0463061T3 publication Critical patent/DK0463061T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK90905065.0T 1989-03-17 1990-03-13 Controlled-release tilførselsindretning til afgivelse af makromolekylære proteiner DK0463061T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32474089A 1989-03-17 1989-03-17

Publications (1)

Publication Number Publication Date
DK0463061T3 true DK0463061T3 (da) 1993-07-12

Family

ID=23264894

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90905065.0T DK0463061T3 (da) 1989-03-17 1990-03-13 Controlled-release tilførselsindretning til afgivelse af makromolekylære proteiner

Country Status (9)

Country Link
EP (1) EP0463061B1 (de)
JP (1) JPH04504122A (de)
AT (1) ATE90203T1 (de)
AU (1) AU634529B2 (de)
DE (1) DE69001898T2 (de)
DK (1) DK0463061T3 (de)
ES (1) ES2042292T3 (de)
NO (1) NO913649D0 (de)
WO (1) WO1990011070A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ286242A (en) * 1991-03-26 1997-11-24 Csl Ltd Use of veterinary implant as a single dose vaccination system: rupturable polymer film coating around core of active agent and water soluble excipient
DK0590060T3 (da) * 1991-06-21 1998-05-11 Univ Cincinnati Oralt indgivelige terapeutiske proteiner samt fremgangsmåde til fremstilling
US6613332B1 (en) 1991-06-21 2003-09-02 The University Of Cincinnati Oral administration of therapeutic proteins
WO1993013792A1 (en) * 1992-01-13 1993-07-22 Pitman-Moore, Inc. Delayed release device for transition metal/protein complexes
US5260069A (en) * 1992-11-27 1993-11-09 Anda Sr Pharmaceuticals Inc. Pulsatile particles drug delivery system
EP0603992B2 (de) * 1992-12-22 2000-12-06 University Of Cincinnati Orale Verabreichung von immunologischen aktiven Biomolekülen und anderen therapeutischen Proteinen
KR100260632B1 (ko) * 1992-12-28 2000-07-01 성재갑 이식형 소마토트로핀 조성물
DE4342091A1 (de) * 1993-12-09 1995-06-14 Asta Medica Ag Erzeugnisse zur Anwendung von initial hohen Dosen von Cetrorelix und Herstellung einer Kombinationspackung zur Verwendung bei Therapie von Krankheiten
KR19990071255A (ko) 1998-02-28 1999-09-15 성재갑 소마토트로핀과 비타민의 합제 조성물
GB9808052D0 (en) 1998-04-17 1998-06-17 Secr Defence Implants for administering substances and methods of producing implants
DE19820529A1 (de) * 1998-05-08 1999-11-11 Lohmann Therapie Syst Lts Wirkstoff enthaltende orale und mucosale Zubereitung mit steuerbarer Wirkstofffreisetzung und ihre Verwendung
EP1064934A1 (de) 1999-06-30 2001-01-03 Applied Research Systems ARS Holding N.V. Gefriergetrocknete GRF-enthaltende Arzneimittel
ES2392393T3 (es) * 1999-07-30 2012-12-10 Capsugel Belgium Nv Forma de dosificación farmacéutica de múltiples componentes
JP2004513877A (ja) * 2000-06-28 2004-05-13 アンジオジェニックス，アイエヌシー． 放出制御アルギニン製剤
AUPR602401A0 (en) * 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release delivery system
AUPR602501A0 (en) * 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release pharmaceutical composition
US20030050620A1 (en) * 2001-09-07 2003-03-13 Isa Odidi Combinatorial type controlled release drug delivery device
EP2112920B1 (de) 2003-06-26 2018-07-25 Intellipharmaceutics Corp. Protonenpumpeninhibitoren enthaltende kapseln, die verschieden aufgebaute untereinheiten zur verzögerten wirkstofffreisetzung enthalten
US8394409B2 (en) 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
JP5244394B2 (ja) * 2004-11-10 2013-07-24 トルマー セラピューティクス， インコーポレイテッド． 安定化されたポリマー送達系
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
CN101903014B (zh) * 2007-12-21 2014-04-16 默克专利股份有限公司 固体内核中包含生长激素的固体脂质微囊
US9023896B2 (en) 2009-05-04 2015-05-05 Psivida Us, Inc. Porous silicon drug-eluting particles
AU2011323524B2 (en) 2010-11-01 2016-12-08 Eyepoint Pharmaceuticals Us, Inc. Bioerodible silicon-based devices for delivery of therapeutic agents
JP2016512839A (ja) 2013-03-15 2016-05-09 シヴィダ・ユーエス・インコーポレイテッドＰｓｉｖｉｄａ Ｕｓ， Ｉｎｃ． 治療物質の送達のための生体内分解性ケイ素系組成物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2738303A (en) * 1952-07-18 1956-03-13 Smith Kline French Lab Sympathomimetic preparation
JPS56140915A (en) * 1980-04-07 1981-11-04 Yamanouchi Pharmaceut Co Ltd Pharmaceutical preparation for solid drug
US4590062A (en) * 1984-04-16 1986-05-20 Tech Trade Corp. Dry direct compression compositions for controlled release dosage forms
US4666704A (en) * 1985-05-24 1987-05-19 International Minerals & Chemical Corp. Controlled release delivery system for macromolecules
US4837381A (en) * 1986-08-11 1989-06-06 American Cyanamid Company Compositions for parenteral administration and their use
EP0321481B1 (de) * 1986-08-28 1994-06-01 Enzacor Properties Limited Mikrogranuläre zubereitung zur verabreichung biologisch aktiver stoffe in den eingeweideregionen von tieren
KR940000065B1 (ko) * 1986-08-28 1994-01-05 코 사이 잉 토마스 동물 성장 촉진제
JP2792862B2 (ja) * 1988-07-30 1998-09-03 寛治 高田 経口腸溶製剤

Also Published As

Publication number Publication date
JPH04504122A (ja) 1992-07-23
DE69001898T2 (de) 1993-09-23
ES2042292T3 (es) 1993-12-01
EP0463061B1 (de) 1993-06-09
DE69001898D1 (de) 1993-07-15
WO1990011070A1 (en) 1990-10-04
ATE90203T1 (de) 1993-06-15
AU5279290A (en) 1990-10-22
EP0463061A1 (de) 1992-01-02
NO913649L (no) 1991-09-16
AU634529B2 (en) 1993-02-25
NO913649D0 (no) 1991-09-16

Similar Documents

Publication Publication Date Title
DK0463061T3 (da) Controlled-release tilførselsindretning til afgivelse af makromolekylære proteiner
ATE90557T1 (de) Mikrokapsel mit verzoegerter freigabe fuer wasserloesliche arzneistoffe.
DE60001835D1 (de) Mesalazine enthaltende pharmazeutische zusammensetzungen mit gesteuerte freisetzung
KR900009106A (ko) 체계속으로의 유체의 잠입을 조절하는 수단을 포함하는 전달시스템
ATE211907T1 (de) Osmotisches arzneimittelfreisetzungssystem
ES2037082T3 (es) Una composicion para la liberacion controlada de un farmaco.
ES2157975T3 (es) Soluciones farmaceuticas con solubilidad mejorada.
KR900007397A (ko) 서방성 제제
DE3583072D1 (de) Tablette mit verzoegerter freisetzung.
IE871584L (en) Sustained release capsule.
DE68909772T2 (de) Diclofenac-Natrium-Arzneizubereitung mit verlängerter Wirkstoffabgabe.
GR3026721T3 (en) Preparation for controlled release of drugs for ruminants
ES2022454B3 (es) Sistema terapeutico para la liberacion controlada de drogas.
CO4970832A1 (es) Nuevas formulaciones y procesos para su fabricacion
DK0559145T3 (da) Lægemiddel til truende abort
FR2748209B1 (fr) Composition pharmaceutique a base de matrices lipophiles stabilisees pour la liberation controlee de principes actifs
ATE234608T1 (de) Mikrokapseln mit verzögerter freisetzung von wirkstoffen
DE69012742D1 (de) Azolderivate und fungizide Medikamente, diese als wirkende Komponente enthaltend.
CA2348841A1 (en) Improved growth stimulant compositions
DE69725155D1 (de) Pharmazeutische zubereitungen enthaltend eine kombination aus isosorbid-nitrat und acetylsalicylsaeure
ECSP972004A (es) Absorcion programada de una substancia farmaceutica 2,6- dimetil 4-(2 nitrofenil) -1,4- dihidropiridin- 3,5- dicarboxilato de dimetilo ( nifedipina)
DE68907091T2 (de) Scleroglucan und Wirkstoff enthaltende pharmazeutische Tabletten und Kapselgranulate.
NO173589C (no) Fremgangsmaate for fremstilling av en partikkel inneholdende et vaeskeopploeselig fast stoff
MX9203154A (es) Sistema terapeutico de liberacion regulada para formulaciones farmaceuticas liquidas.